JPWO2022270607A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022270607A5
JPWO2022270607A5 JP2023530132A JP2023530132A JPWO2022270607A5 JP WO2022270607 A5 JPWO2022270607 A5 JP WO2022270607A5 JP 2023530132 A JP2023530132 A JP 2023530132A JP 2023530132 A JP2023530132 A JP 2023530132A JP WO2022270607 A5 JPWO2022270607 A5 JP WO2022270607A5
Authority
JP
Japan
Prior art keywords
compound
salt
group
disease
calpain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023530132A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022270607A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/025205 external-priority patent/WO2022270607A1/ja
Publication of JPWO2022270607A1 publication Critical patent/JPWO2022270607A1/ja
Publication of JPWO2022270607A5 publication Critical patent/JPWO2022270607A5/ja
Pending legal-status Critical Current

Links

JP2023530132A 2021-06-24 2022-06-23 Pending JPWO2022270607A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021105163 2021-06-24
PCT/JP2022/025205 WO2022270607A1 (ja) 2021-06-24 2022-06-23 蛍光プローブ

Publications (2)

Publication Number Publication Date
JPWO2022270607A1 JPWO2022270607A1 (https=) 2022-12-29
JPWO2022270607A5 true JPWO2022270607A5 (https=) 2025-05-29

Family

ID=84544379

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023530132A Pending JPWO2022270607A1 (https=) 2021-06-24 2022-06-23

Country Status (8)

Country Link
US (1) US20240279710A1 (https=)
EP (1) EP4361166A4 (https=)
JP (1) JPWO2022270607A1 (https=)
KR (1) KR20240024104A (https=)
CN (1) CN117480175A (https=)
AU (1) AU2022297106A1 (https=)
CA (1) CA3219184A1 (https=)
WO (1) WO2022270607A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024177153A1 (https=) * 2023-02-24 2024-08-29
EP4710949A1 (en) 2023-05-12 2026-03-18 Goryo Chemical, Inc. Lyophilized preparation, lyophilized solution, methods for producing same, and liquid agent
WO2025110087A1 (ja) * 2023-11-21 2025-05-30 五稜化薬株式会社 キモトリプシン検出試薬及び検出方法
CN120923579B (zh) * 2025-10-11 2026-02-03 四川维亚本苑生物科技有限公司 一种高效荧光素探针及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826656B1 (fr) * 2001-06-29 2003-09-12 Genethon Iii Methode de detection de l'activite de la calpaine 3 dans un echantillon biologique et peptides pour la mise en oeuvre de ladite methode
CA2816041C (en) * 2010-12-29 2019-01-08 Arrowhead Research Corporation In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
US20160102336A1 (en) * 2013-03-04 2016-04-14 The University Of Tokyo Fluorescent probe for detecting activity of calpain
JP6881294B2 (ja) * 2015-02-27 2021-06-02 国立大学法人 東京大学 カルパイン活性検出蛍光プローブ

Similar Documents

Publication Publication Date Title
JPWO2022270607A5 (https=)
EP1364659B1 (en) Remedies for urinary diseases comprising lpa receptor controlling agents
Dennis et al. hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery.
KR101591206B1 (ko) 치료적 특성을 갖는 베타 1-42 특이적인 단일클론성 항체
RU2604181C2 (ru) Применение антитела против амилоида бета при глазных заболеваниях
AU2019264073B2 (en) 2-amino-2-(1,2,3-triazole-4-yl)propane-1,3-diol derivative of novel compound for directly inhibiting ASM activity, and use thereof
US20110081428A1 (en) Use of thioflavin-like compounds to increase life span and/or health span
CN117480175A (zh) 荧光探针
US20040152868A1 (en) Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease
JP2008543947A (ja) チオール感受性の正の変力物質
ES2657701T3 (es) Compuestos de 2,6-diaminopiridina adecuados para tratar enfermedades asociadas con proteínas amiloides o para tratar enfermedades oculares
US20210261633A1 (en) Mutated tau protein fragment and use thereof
JP3973561B2 (ja) カリウムチャネル開口薬
EP3478708A2 (en) Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregation-driving segments
JP6808154B2 (ja) アダマンタン誘導体およびその使用
CN109490527A (zh) Dbn1蛋白在制备神经变性疾病诊断药物中的应用
JP2011511296A (ja) 対象体でのガン状態の免疫検出
Baykan et al. Impairment in flow-mediated vasodilatation of the brachial artery in acromegaly
RU2860853C2 (ru) Флуоресцентные зонды
Sirli et al. M1273 Can Acoustic Radiation Force Impulse Elastography (ARFI) Predict the Complications of Liver Cirrhosis?
RU2004109540A (ru) Способ определения послеоперационной остроты зрения
AU684009B2 (en) Peptides for diagnostics
RU2837464C1 (ru) Способ диагностики аномалий зубочелюстной системы
Yoshitomi et al. Left ventricular systolic and diastolic function and mass before and after antihypertensive treatment in patients with essential hypertension
US20060040254A1 (en) Method for identifying bronchoconstriction relaxing substances